HAS 535 Week 1 Discussion
"CDC and BMA"Â Â Please respond to the following:
·        From the first two (2) e-Activities, give a synopsis of the various challenges facing health care professionals, and determine whether or not you believe these professionals can formulate predictive plans from both agencies. Be specific, giving supporting rationales for your observations.
·        From the third e-Activity, give a comprehensive critiqued evaluation of your state’s DOH disease-management protocols. Also, from the analysis of the case study, determine if your state’s standpoint on the disease is adequate. Be specific, articulating the actions that can be taken to improve your state’s DOH.
"CDC, BMA and Your State’s DOH"  Please respond to the following:
·        From the first two (2) e-Activities, functioning as an investigator collaborating with the two (2) agencies to obtain vital statistics on your particular demographic, you are tasked with obtaining the logistics and planning phase of the report. Prioritize the items you would consider when formulating comprehensive letters of inquiry to the agencies.
·        From the third e-Activity, suppose you are the County Department of Health, Director of STDs Tracking and Surveillance System, tasked with drafting a memo to your state’s head of the DOH about ways to optimize your county’s efficiency. Prepare a rudimentary list of possible questions to articulate your concerns. Provide a rationale for the questions you have chosen.
Answers
Status NEW
Posted 15 Sep 2019 12:09 PM
My Price 7.00
HAS----------- 53-----------5 W-----------eek----------- 1 -----------Dis-----------cus-----------sio-----------n-----------
Attachments
file 1568556826-HAS 535 Week 1 Discussion.docx preview (798 words )
H-----------AS -----------535----------- We-----------ek -----------1 D-----------isc-----------uss-----------ion----------- &-----------quo-----------t;C-----------DC -----------and----------- BM-----------A&q-----------uot-----------;Â -----------Â P-----------lea-----------se -----------res-----------pon-----------d t-----------o t-----------he -----------fol-----------low-----------ing-----------: -----------Fro-----------m t-----------he -----------fir-----------st -----------two----------- (2-----------) e------------Ac-----------tiv-----------iti-----------es,----------- gi-----------ve -----------a s-----------yno-----------psi-----------s o-----------f t-----------he -----------var-----------iou-----------s c-----------hal-----------len-----------ges----------- fa-----------cin-----------g h-----------eal-----------th -----------car-----------e p-----------rof-----------ess-----------ion-----------als-----------, a-----------nd -----------det-----------erm-----------ine----------- wh-----------eth-----------er -----------or -----------not----------- yo-----------u b-----------eli-----------eve----------- th-----------ese----------- pr-----------ofe-----------ssi-----------ona-----------ls -----------can----------- fo-----------rmu-----------lat-----------e p-----------red-----------ict-----------ive----------- pl-----------ans----------- fr-----------om -----------bot-----------h a-----------gen-----------cie-----------s. -----------Be -----------spe-----------cif-----------ic,----------- gi-----------vin-----------g s-----------upp-----------ort-----------ing----------- ra-----------tio-----------nal-----------es -----------for----------- yo-----------ur -----------obs-----------erv-----------ati-----------ons-----------. -----------Fro-----------m t-----------he -----------thi-----------rd -----------e-A-----------cti-----------vit-----------y, -----------giv-----------e a----------- co-----------mpr-----------ehe-----------nsi-----------ve -----------cri-----------tiq-----------ued-----------
Not Rated(0)